Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Examining the role of lipid mediators in diabetic retinopathy.

Busik JV, Esselman WJ, Reid GE.

Clin Lipidol. 2012 Dec 1;7(6):661-675.

2.

The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.

Opreanu M, Tikhonenko M, Bozack S, Lydic TA, Reid GE, McSorley KM, Sochacki A, Perez GI, Esselman WJ, Kern T, Kolesnick R, Grant MB, Busik JV.

Diabetes. 2011 Sep;60(9):2370-8. doi: 10.2337/db10-0550. Epub 2011 Jul 19.

3.

Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.

Opreanu M, Lydic TA, Reid GE, McSorley KM, Esselman WJ, Busik JV.

Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3253-63. doi: 10.1167/iovs.09-4731. Epub 2010 Jan 13.

4.

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock.

Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M, Yakubova N, Caballero S, Player D, Nakagawa T, Afzal A, Kielczewski J, Sochacki A, Hasty S, Li Calzi S, Kim S, Duclas SK, Segal MS, Guberski DL, Esselman WJ, Boulton ME, Grant MB.

J Exp Med. 2009 Dec 21;206(13):2897-906. doi: 10.1084/jem.20090889. Epub 2009 Nov 23.

5.

Complementary precursor ion and neutral loss scan mode tandem mass spectrometry for the analysis of glycerophosphatidylethanolamine lipids from whole rat retina.

Lydic TA, Busik JV, Esselman WJ, Reid GE.

Anal Bioanal Chem. 2009 May;394(1):267-75. doi: 10.1007/s00216-009-2717-9. Epub 2009 Mar 11.

6.
7.

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.

Dang Y, Wang X, Esselman WJ, Zheng YH.

J Virol. 2006 Nov;80(21):10522-33. Epub 2006 Aug 18. Erratum in: J Virol. 2011 May;85(10):5243.

8.
10.

Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells.

Chen W, Jump DB, Grant MB, Esselman WJ, Busik JV.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):5016-22.

PMID:
14578429
11.

Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways.

Lee K, Esselman WJ.

Free Radic Biol Med. 2002 Oct 15;33(8):1121-32.

PMID:
12374624
12.

Substrate conformational restriction and CD45-catalyzed dephosphorylation of tail tyrosine-phosphorylated Src protein.

Wang D, Esselman WJ, Cole PA.

J Biol Chem. 2002 Oct 25;277(43):40428-33. Epub 2002 Aug 13.

13.
14.

Regulation of the calcium/NF-AT T cell activation pathway by the D2 domain of CD45.

Wang Y, Liang L, Esselman WJ.

J Immunol. 2000 Mar 1;164(5):2557-64.

15.

Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis.

Wang Y, Guo W, Liang L, Esselman WJ.

J Biol Chem. 1999 Mar 12;274(11):7454-61.

16.

Identification of in vivo phosphorylation sites of CD45 protein-tyrosine phosphatase in 70Z/3.12 cells.

Kang S, Liao Pc, Gage DA, Esselman WJ.

J Biol Chem. 1997 Apr 25;272(17):11588-96.

17.

Protein tyrosine phosphatases: cellular regulators of human breast cancer?

Zhai YF, Wirth JJ, Welsch CW, Esselman WJ.

Cancer Treat Res. 1996;83:107-25. No abstract available.

PMID:
8826644
18.

LAR-PTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells.

Zhai Y, Wirth J, Kang S, Welsch CW, Esselman WJ.

Mol Carcinog. 1995 Oct;14(2):103-10.

PMID:
7576097
19.

Elevation of lymphocyte CD45 protein tyrosine phosphatase activity during mitosis.

Melkerson-Watson LJ, Waldmann ME, Gunter AD, Zaroukian MH, Esselman WJ.

J Immunol. 1994 Sep 1;153(5):2004-13.

PMID:
8051405
20.

Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.

Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW.

Cancer Res. 1993 May 15;53(10 Suppl):2272-8.

21.
22.

Lineage switch macrophages can present antigen.

Bretz JD, Chen SC, Redenius D, Chang HL, Esselman WJ, Schwartz RC.

Dev Immunol. 1992;2(4):249-61.

23.

Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use.

Chang HL, Lefrancois L, Zaroukian MH, Esselman WJ.

J Immunol. 1991 Sep 1;147(5):1687-93.

PMID:
1831832
24.

Characterization of the CD45 molecule on murine intestinal intraepithelial lymphocytes.

Goodman TG, Chang HL, Esselman WJ, LeCorre R, Lefrancois L.

J Immunol. 1990 Nov 1;145(9):2959-66.

PMID:
1976708
25.

T200 alternate exon use in murine lymphoid cells determined by reverse transcription-polymerase chain reaction.

Chang HL, Zaroukian MH, Esselman WJ.

J Immunol. 1989 Jul 1;143(1):315-21.

PMID:
2471739
27.
28.

Surface Ly-5 glycoprotein in murine natural killer (NK) cell development, target binding and cytotoxicity.

Zaroukian MH, Gilbert CW, Esselman WJ.

Immunol Invest. 1986 Dec;15(8):813-32.

PMID:
3596678
29.

Poly-N-acetyllactosamine alterations of Thy-1 glycoprotein in lymphocyte differentiation.

Morrison MH, Lynch RA, Esselman WJ.

Mol Immunol. 1986 Jan;23(1):63-72.

PMID:
2870429
30.

Interaction of gangliosides with B cells in splenic fragment cultures.

Chaney WG, Miller HC, Klinman NR, Esselman WJ.

Cell Immunol. 1984 Jun;86(1):165-70.

PMID:
6609776
31.

Molecular weight and charge heterogeneity of Thy-1 glycoprotein in different populations of T-cells.

Morrison MH, Chaney WG, Esselman WJ.

Mol Immunol. 1984 May;21(5):405-13.

PMID:
6146094
32.

Regulation of B cell tolerance by murine gangliosides.

Miller HC, Chaney WG, Klinman NR, Esselman WJ.

Cell Immunol. 1982 Mar 1;67(2):390-5. No abstract available.

PMID:
6805963
33.

Neuraminidase sensitivity of Thy-1 active glycoconjugates.

Wang TJ, Miller HC, Esselman WJ.

Mol Immunol. 1980 Nov;17(11):1389-97. No abstract available.

PMID:
6162097
34.

Detection of Thy-1.2 membrane complexes shed from thymocytes and lymphoma cells by an immunoradiometric assay.

Schwarz MS, Wang TJ, Miller HC, Esselman WJ.

Mol Immunol. 1980 Nov;17(11):1381-8. No abstract available.

PMID:
6162096
35.

Antigen induced modulation by shed lymphocyte membrane gangliosides.

Correa M, Miller HC, Esselman WJ.

Immunol Commun. 1980;9(6):543-57.

PMID:
6159304
36.

Radiolabeling and isolation of Thy-1 active glycolipids from murine brain and lymphoma cell lines.

Kato KP, Wang TJ, Esselman WJ.

J Immunol. 1979 Nov;123(5):1977-84. No abstract available.

PMID:
90698
37.

Soluble factors containing Thy-1 antigen shed from lymphoblastoid cells modulate in vitro plaque-forming cell response.

Freimuth WW, Miller HC, Esselman WJ.

J Immunol. 1979 Jul;123(1):201-8. No abstract available.

PMID:
376740
38.

Thy-1 antigenicity is associated with glycolipids of brain and thymocytes.

Wang TJ, Freimuth WW, Miller HC, Esselman WJ.

J Immunol. 1978 Oct;121(4):1361-5. No abstract available.

PMID:
308963
39.

Release of thy-1.2 and thy-1.1 from lymphoblastoid cells: partial characterization and antigenicity of shed material.

Freimuth WW, Esselman WJ, Miller HC.

J Immunol. 1978 May;120(5):1651-8. No abstract available.

PMID:
77877
40.

Modulation of B cell responses by glycolipid released from antigen-stimulated T cells.

Esselman WJ, Miller HC.

J Immunol. 1977 Dec;119(6):1994-2000. No abstract available.

PMID:
334979
41.

Membrane expression of Thy-1,2 and GM1 ganglioside on differentiating T lymphocytes.

Milewicz C, Miller HC, Esselman WJ.

J Immunol. 1976 Nov;117(5 Pt.2):1774-80.

PMID:
1086862
42.
43.

Identification of theta-bearing T-cells derived from bone marrow cells treated with thymic factor.

Miller HC, Esselman WJ.

Ann N Y Acad Sci. 1975 Feb 28;249:54-60. No abstract available.

PMID:
1079436
44.

Products of linoleic hydroperoxide-decomposing enzyme of alfalfa seed.

Esselman WJ, Clagett CO.

J Lipid Res. 1974 Mar;15(2):173-8.

45.

Brain and thymus lipid inhibition of antibrain-associated theta-cytotoxicity.

Esselman WJ, Miller HC.

J Exp Med. 1974 Feb 1;139(2):445-50. No abstract available.

46.

Glycosphingolipids of membrane fractions from normal and transplanted canine kidney.

Esselman WJ, Ackermann JR, Sweeley CC.

J Biol Chem. 1973 Nov 10;248(21):7310-7. No abstract available.

47.

Structure of a pentahexosylceramide (Forssman hapten) from canine intestine and kidney.

Sung SS, Esselman WJ, Sweeley CC.

J Biol Chem. 1973 Sep 25;248(18):6528-33. No abstract available.

48.

The isolation and specificity of alfalfa lipoxygenase.

Chang CC, Esselman WJ, Clagett CO.

Lipids. 1971 Feb;6(2):100-6. No abstract available.

PMID:
5102251

Supplemental Content

Loading ...
Support Center